How to win: Unlocking Space for Business: In-orbit R&D and manufacturing of pharmaceuticals RFI

About this contract

The UK Space Agency is working across government, regulators, industry and healthcare to help create the conditions needed for the in-orbit pharmaceuticals manufacturing and drug discovery market to develop. USB has played a convening role in bringing together the Medicines and Healthcare products Regulatory Agency (MHRA), the Civil Aviation Authority (CAA) and the Regulatory Innovation Office (RIO) within the Department for Business, Innovation, Science and Trade (BIST) to publish a joint statement on regulatory clarity for in-orbit manufacturing of pharmaceuticals. We are also working with MHRA to develop a regulatory roadmap for space-enabled pharmaceutical manufacturing, to provide greater clarity and confidence for industry. Following sustained evidence-gathering from the Unlocking Space Portfolio, including participation in the recent UK-Swiss Microgravity Biopharma Dialogue, clear pain-points and barriers to the adoption of in-orbit manufacturing of pharmaceuticals have emerged, which are currently experienced by UK stakeholders including prospective end-users, space biotech companies and investors. This Request for Information (RFI) builds directly on this Dialogue, and t

How to win contracts like this

• ✓Answer against the marking scheme, not the question text — Department for Science, Innovation & Technology scores each response, so map your evidence to the published criteria and weightings.
• ✓Lead with evidenced capability and social value — for services work these usually outweigh price.
• ✓Show recent, comparable delivery: name similar services contracts you've delivered for public bodies, with measurable outcomes.
• ✓Start early: deadlines are tight and a strong bid takes iteration.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources